Singapore, Nov. 7 -- Olympus Corporation has announced its Corporate Strategy in central Tokyo. The announcement follows the company's earlier announcement in January this year, when significant changes in governance, the headquarters move of the Therapeutic Solutions business to the US, as well as a cost containment program were announced as a starting point of the company's extensive transformation efforts.

To achieve an operating profit margin of 20% or above at the fiscal year 2023 March, Olympus introduced four core elements:

Focus the corporate portfolio centering on Medical, the company's key contributor to revenue and profit with the greatest market growth potential. The Imagingand Scientific Solutions divisions remain crucial c...